Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2-Chloro-4,5-dimethylphenol is a chlorinated phenolic compound with the molecular formula C8H9ClO and a molecular weight of approximately 156.61 g/mol. It is structurally related to other chlorinated xylenols and is characterized by a chlorine atom at the second position and methyl groups at the fourth and fifth positions on the aromatic ring[1][2][6]. This compound exhibits notable antimicrobial activity against both Gram-positive and Gram-negative bacteria such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. Its primary mechanism of action involves disruption of bacterial cell membranes leading to cell lysis[4]. It has been investigated for use in disinfectants and biocidal formulations but does not have established pharmaceutical indications or approvals as a drug for human therapeutic use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2-chloro-4,5-dimethylphenol.